196 related articles for article (PubMed ID: 11120049)
21. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
22. Prolonged rat cardiac allograft survival using adenoviral vector containing the CTLA4Ig gene.
Kita Y; Li XK; Hayashi S; Funeshima N; Enosawa S; Tamura A; Suzuki K; Kazui T; Amemiya H; Suzuki S
Transplant Proc; 1998 Jun; 30(4):1079-80. PubMed ID: 9636437
[No Abstract] [Full Text] [Related]
23. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft.
Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S
Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432
[No Abstract] [Full Text] [Related]
24. Review of CTLA4Ig use for allograft immunosuppression.
Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
[No Abstract] [Full Text] [Related]
25. Prolongation of rat small bowel allograft survival by CTLA-4 IG.
Tarumi K; Yagihashi A; Murakami M; Uede T; Hirata K
Transplant Proc; 1998 Sep; 30(6):2596-9. PubMed ID: 9745507
[No Abstract] [Full Text] [Related]
26. Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation.
Koshiba T; Ji P; Tanaka K; McMaster P; Van Damme B; Waer M; Pirenne J
Transplant Proc; 2000 Sep; 32(6):1255-7. PubMed ID: 10995936
[No Abstract] [Full Text] [Related]
27. Immunosuppressive action of FTY720 for renal allograft a rat model.
Kunikata S; Nagano T; Nishioka T; Akiyama T; Kurita T
Transplant Proc; 1999; 31(1-2):1157-9. PubMed ID: 10083517
[No Abstract] [Full Text] [Related]
28. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
Yang Z; Rostami S; Koeberlein B; Barker CF; Naji A
Transplantation; 1999 Jun; 67(12):1517-23. PubMed ID: 10401757
[TBL] [Abstract][Full Text] [Related]
29. Induction and maintenance of tolerance by CTLA-4IG in rat small bowel allografts.
Tarumi K; Yagihashi A; Tsuruma T; Koide S; Sasaki K; Hirata K
Transplant Proc; 1999; 31(1-2):878-81. PubMed ID: 10083385
[No Abstract] [Full Text] [Related]
30. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
[No Abstract] [Full Text] [Related]
31. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas.
Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Nogimura H; Ohi S; Kageyama Y; Matsushita K; Ito Y; Takahashi T; Suzuki K; Suzuki S; Kazui T
Transplant Proc; 2000 Nov; 32(7):2036-7. PubMed ID: 11120055
[No Abstract] [Full Text] [Related]
32. Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model.
Konishi K; Inobe M; Yamada A; Murakami M; Todo S; Uede T
J Heart Lung Transplant; 2002 Jun; 21(6):692-700. PubMed ID: 12057704
[TBL] [Abstract][Full Text] [Related]
33. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
Rehman A; Tu Y; Flye MW
Transplant Proc; 1996 Apr; 28(2):660-1. PubMed ID: 8623331
[No Abstract] [Full Text] [Related]
34. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
Bolling SF; Lin H; Wei RQ; Turka LA
J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of adenovirus-mediated gene transfer with CTLA4Ig in allo and xeno-transplantation.
Hayashi S; Dai-Kaku L; Namii Y; Kato T; Tokoro T; Kobayashi T; Yokoyama I; Hamada H; Nakao A
Transplant Proc; 2000 Nov; 32(7):2520-1. PubMed ID: 11120276
[No Abstract] [Full Text] [Related]
36. FTY720: mechanisms of action and its effect on organ transplantation (review).
Suzuki S
Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
[No Abstract] [Full Text] [Related]
37. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
[No Abstract] [Full Text] [Related]
38. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
[No Abstract] [Full Text] [Related]
39. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene.
Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Tamura A; Suzuki K; Amemiya H; Hayashi S; Kazui T; Suzuki S
Transplantation; 1999 Sep; 68(6):758-66. PubMed ID: 10515375
[TBL] [Abstract][Full Text] [Related]
40. The time course of CTLAIg effect on cardiac allograft rejection.
Bolling SF; Lin H; Turka LA
J Surg Res; 1996 Jun; 63(1):320-3. PubMed ID: 8661218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
